Deutsche Bank AG Has $3.67 Million Holdings in Cabot Corporation $CBT

Deutsche Bank AG decreased its stake in Cabot Corporation (NYSE:CBT) by 8.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,123 shares of the specialty chemicals company’s stock after selling 4,036 shares during the period. Deutsche Bank AG owned 0.08% of Cabot worth $3,668,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Beverly Hills Private Wealth LLC grew its holdings in shares of Cabot by 3.6% in the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company’s stock valued at $326,000 after acquiring an additional 135 shares in the last quarter. Isthmus Partners LLC grew its holdings in shares of Cabot by 4.6% in the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company’s stock valued at $354,000 after acquiring an additional 186 shares in the last quarter. CWM LLC grew its holdings in shares of Cabot by 55.0% in the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock valued at $50,000 after acquiring an additional 213 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Cabot by 26.1% in the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company’s stock valued at $141,000 after acquiring an additional 352 shares in the last quarter. Finally, Captrust Financial Advisors grew its holdings in shares of Cabot by 4.4% in the 4th quarter. Captrust Financial Advisors now owns 9,489 shares of the specialty chemicals company’s stock valued at $866,000 after acquiring an additional 399 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Trading Up 0.6%

Cabot stock opened at $78.59 on Tuesday. Cabot Corporation has a 52 week low of $70.40 and a 52 week high of $117.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The stock has a market capitalization of $4.18 billion, a P/E ratio of 10.27 and a beta of 0.87. The stock has a 50-day simple moving average of $76.40 and a 200 day simple moving average of $79.00.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.10. The firm had revenue of $923.00 million during the quarter, compared to the consensus estimate of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 11th. Shareholders of record on Friday, August 29th will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.3%. Cabot’s dividend payout ratio (DPR) is presently 23.53%.

Analyst Upgrades and Downgrades

CBT has been the subject of several analyst reports. Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. UBS Group set a $82.00 price target on Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th.

Insider Transactions at Cabot

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the completion of the sale, the chief executive officer directly owned 361,518 shares in the company, valued at $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 3.03% of the stock is owned by company insiders.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.